Julianne Bruno

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Garrett Winslow, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Julianne Bruno

Form 4 holding Chief Operating Officer

CRISPR Therapeutics AG

Security class
Common Shares
Shares / value
10,544
Estimated value
$434,729
Report date
21 Mar 2025
Price
$41.23
Ownership
Direct
Form 4 holding Chief Operating Officer

CRISPR Therapeutics AG

Security class
Common Shares
Shares / value
7,088
Estimated value
$292,238
Report date
20 Mar 2025
Price
$41.23
Ownership
The Julianne Bruno 2022 GRAT
Form 4 holding Chief Operating Officer

CRISPR Therapeutics AG

Security class
Stock Option (Right to Buy)
Shares / value
36,666
Estimated value
Report date
14 Mar 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Operating Officer

CRISPR Therapeutics AG

Security class
Restricted Stock Units
Shares / value
11,250
Estimated value
Report date
20 Mar 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

Galecto, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
09 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Julianne Bruno

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .